Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.
NCT ID: NCT04339686
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
56000 participants
OBSERVATIONAL
2020-04-20
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID.
CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary.
Ct Scan performance will be recorded and analyzed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Clinical Course in COVID19 Patients
NCT04377685
Dynamic Evaluation of COVID-19 Diagnostic Tests
NCT04337996
Assessment of Lung Inflammation With FDG PET/CT in COVID-19
NCT04441489
DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia
NCT03360851
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
NCT04357938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suspicion of COVID 19
Thoracic CT Scan
Retrospective analysis of the thoracic CT scan results compared to final discharge summary
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thoracic CT Scan
Retrospective analysis of the thoracic CT scan results compared to final discharge summary
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu de Poitiers
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guillaume HERPE
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POWER-COVID_CT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.